Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$22.80 USD
+2.30 (11.22%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.73 -0.07 (-0.31%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.80 USD
+2.30 (11.22%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.73 -0.07 (-0.31%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
Zacks News
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of -16.22% and 14.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Hims & Hers Health, Inc. (HIMS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hims & Hers Health, Inc. (HIMS) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of -10% and 11.42%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Syneos Health (SYNH) Q4 Earnings Beat Estimates
by Zacks Equity Research
Syneos Health (SYNH) delivered earnings and revenue surprises of 3.50% and 2.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Hims & Hers Health, Inc. (HIMS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 80.85% and 0.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
UBER Teams Up With Hims & Hers to Deliver Personal Care Products
by Zacks Equity Research
UBER expands its delivery network, partnering with Hims & Hers to offer on-demand delivery of personal wellness products to customers across the United States.
Here's Why Urban Outfitters (URBN) Stock Increases 20% YTD
by Zacks Equity Research
Urban Outfitters' (URBN) solid business initiatives including the FP Movement will continue boosting growth. Its merchandising strategy is also impressive.
Urban Outfitters (URBN) Rides High on Strategies: Apt to Hold
by Zacks Equity Research
Urban Outfitters' (URBN) solid business initiatives including the FP Movement will continue boosting growth. Its merchandising strategy is also impressive.
Urban Outfitters (URBN) Gains 25% in 6 Months: What's Ahead?
by Zacks Equity Research
Urban Outfitters' (URBN) robust business initiatives including the FP Movement will continue boosting growth. Its merchandising strategy is also impressive.
Is the Options Market Predicting a Spike in Hims & Hers (HIMS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Hims & Hers (HIMS) stock based on the movements in the options market lately.
Here's Why Urban Outfitters (URBN) is Ahead of Industry YTD
by Zacks Equity Research
Urban Outfitters' (URBN) robust business initiatives including the FP Movement will continue boosting growth. Its merchandising strategy is also impressive.
Urban Outfitters' (URBN) Alliance With Hims & Hers Augurs Well
by Zacks Equity Research
Urban Outfitters (URBN) partners with Hims & Hers Health to offer personalized wellness offerings to customers.